| | | | Events
|
Gene Based Vaccines: Optimising Development and Delivery
13 September 2010 - 14 September 2010
Analysing novel vaccine design and delivery methods in order to translate evidence into clinical success.
Further developments in electroporation and other novel delivery methods have changed the vaccines landscape. Therefore, this year we will be evaluating the newly developed delivery techniques and how to overcome the challenges faced.
|
|
|
|
6th Annual Achieving Quality & Process Excellence in the Pharmaceutical Industry
15 September 2010 - 17 September 2010
How successful are you in adopting and sustaining consistent, harmonized & compliant quality systems?
Leading Pharmaceutical companies will share their first hand experience with transforming the mindset of people, creating the culture of change and continuous improvement in both Quality and Operational Excellence.
|
|
|
|
JCO 2010 (Journées de Chimie Organique de la Société Chimique de France)
21 September 2010 - 23 September 2010
The JCO 2010, organised by the “Division de Chimie organique” of the “Société Chimique de France”, takes place every 3 years and creates the unique opportunity for the synthetic organic chemists’ community to gather and listen to 16 lectures given by internationally established synthetic organic chemists.
|
|
|
|
Miniaturisation - Micro Scale Bioprocess Development
24 September 2010 - 24 September 2010
The Biopark, Welwyn Garden City,UK
Chair: Professor Gary Lye, Professor of Biochemical Engineering, University College London
Miniaturisation and automation of bioprocess development holds great promise in reducing the time and cost to market of new biopharmaceuticals. This meeting aims to highlight recent technologies used in high throughput bioprocess development, from clone selection through to analysis of final product and formulation.
|
|
|
|
Amorphous Pharmaceutical Materials
27 September 2010 - 28 September 2010
Amorphous Pharmaceutical Materials (Amsterdam) will explore the results and knowledge acquired over the years on perfecting the art of amorphous formation and stabilisation. This will thus ensure consistency of amorphous drugs from the laboratory to manufacture, with the ultimate aim of realising the commercial potential of amorphous forms in pharmaceutical drugs.
|
|
|
|
Pharmaceutical Co-Crystals 2010
27 September 2010 - 29 September 2010
Pharmaceutical Co-Crystals 2010 will explore the results and knowledge acquired over the years on perfecting the art of co-crystal formation and how best to apply it at both the laboratory and manufacturing scale, with the ultimate aim of realising the commercial potential of co-crystals in pharmaceutical drugs.
|
|
|
|
European Pharma Maintenance Masters
30 September 2010 - 01 October 2010
The first annual “European Pharma Maintenance Masters”, held in Berlin, will establish with international Top-speakers a new approach in finding the right maintenance excellence strategy for pharmaceutical manufacturers across Europe.
|
|
|
| |
| |
|